Crystalvue Medical Corporation (TPEX:6527)
Taiwan · Delayed Price · Currency is TWD 72.40
-1.20 (-1.63%)
At close: Jul 9, 2026
Crystalvue Medical Market Cap
Crystalvue Medical has a market cap or net worth of 1.83 billion as of July 9, 2026. Its market cap has decreased by -17.07% in one year.
Market Cap
1.83B
Enterprise Value
1.73B
Revenue
912.86M
Ranking
n/a
PE Ratio
12.97
Stock Price
72.40
Market Cap Chart
Since April 29, 2015, Crystalvue Medical's market cap has increased from 1.04B to 1.83B, an increase of 76.79%. That is a compound annual growth rate of 5.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.83B | -4.86% |
| Dec 31, 2025 | 1.93B | -10.37% |
| Dec 30, 2024 | 2.15B | -1.77% |
| Dec 29, 2023 | 2.19B | 76.51% |
| Dec 30, 2022 | 1.24B | 8.45% |
| Dec 30, 2021 | 1.14B | -3.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bionime | 4.38B |
| SciVision Biotech | 4.07B |
| Maxigen Biotech | 3.64B |
| ICARES Medicus | 3.50B |
| Nang Kuang Pharmaceutical | 3.27B |
| Chi Sheng Pharma & Biotech | 1.84B |
| BenQ Medical Technology | 1.72B |
| Ttbio | 1.61B |